Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc

Bullboard Posts

Comment by TechnicallyHighon Mar 01, 2019 9:37am

38 Views

Post# 29428048

RE:RE:$170M Market Cap... $100M of Inventory...

Chutzpah wrote:

TechnicallyHigh wrote:
What does 1 million grams of pure CBD sell for?

Firstly - no one has pure CBD.. minus Cardiol.

Second.. here are the compariable prices but all have THC contaminent... prices/mL and purity.

Emblem - $85/30mL (92%)
Tilray - $104/40mL (96.3%)
Medreleaf - $125/100mL (57%)
Starseed - $135/50mL (55%)
CanniMed - $160/60mL ( 51%)

Using TLRY as a benchmark... where each bottle at 40mL concentrate contants 1000mg/1g of CBD. At an equivalent $100/1000mg, that would equate to $100M in inventory.

And then you get 3 drugs programs (2 with fast track capabilities)...

Where are you getting the 100M inventory stuff from ? Nothing on the prospectus